Andere Kunden interessierten sich auch für
![Key Policy Challenges and Opportunities to Improve Care for People with Mental Health and Substance Use Disorders]( "Key Policy Challenges and Opportunities to Improve Care for People with Mental Health and Substance Use Disorders")
Key Policy Challenges and Opportunities to Improve Care for People with Mental Health and Substance Use Disorders53,99 €![Opportunities to Improve Opioid Use Disorder and Infectious Disease Services]( "Opportunities to Improve Opioid Use Disorder and Infectious Disease Services")
Opportunities to Improve Opioid Use Disorder and Infectious Disease Services62,99 €![Envisioning a Transformed Clinical Trials Enterprise in the United States]( "Envisioning a Transformed Clinical Trials Enterprise in the United States")
Envisioning a Transformed Clinical Trials Enterprise in the United States48,99 €![The National Imperative to Improve Nursing Home Quality]( "The National Imperative to Improve Nursing Home Quality")
The National Imperative to Improve Nursing Home Quality68,99 €![Implementing a National Cancer Clinical Trials System for the 21st Century]( "Implementing a National Cancer Clinical Trials System for the 21st Century")
Implementing a National Cancer Clinical Trials System for the 21st Century38,99 €![Implementing a National Cancer Clinical Trials System for the 21st Century]( "Implementing a National Cancer Clinical Trials System for the 21st Century")
Implementing a National Cancer Clinical Trials System for the 21st Century37,99 €![Developing a National Registry of Pharmacologic and Biologic Clinical Trials]( "Developing a National Registry of Pharmacologic and Biologic Clinical Trials")
Developing a National Registry of Pharmacologic and Biologic Clinical Trials42,99 €
Despite decades of ongoing efforts to improve racial and ethnic diversity in clinical trials, many gaps remain in achieving demographic representation in clinical studies. In May 2024, the National Academies Forum on Drug Discovery, Development, and Translation, in collaboration with the National Cancer Policy Forum, hosted a public workshop to explore system-level changes and initiatives across organizations and sectors to improve representation, data collection, and reporting in clinical trials and progress tracking in the United States.